Apellis Pharmaceuticals, Inc. · NASDAQ:APLS
Deep Track Capital, LP's stake in Apellis Pharmaceuticals, Inc. fell to 3.55% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Deep Track Capital, LP's stake in Apellis Pharmaceuticals, Inc. fell to 3.55%, 4,532,374 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 3.55%
- Shares
- 4,532,374
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 3.55% | 4,532,374 |
| Deep Track Biotechnology Master Fund, Ltd. | 3.55% | 4,532,374 |
| David Kroin | 3.55% | 4,532,374 |
Source
Related
- Apellis Pharmaceuticals, Inc.
- Deep Track Capital, LP
- Apellis Pharmaceuticals, Inc. shareholders
- Schedule 13G · Deep Track Capital, LP · May 16, 2025
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Rtw Investments, LP · May 15, 2026
- Form 4 · Dunlop A. Sinclair · May 14, 2026
- Form 4 · Chopas James George · May 14, 2026
- Form 4 · Dolsten Mikael · May 14, 2026